Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Healthtrust
Baxter
Dow
McKinsey
Boehringer Ingelheim
Medtronic
Cantor Fitzgerald

Generated: November 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017533

« Back to Dashboard

NDA 017533 describes KLONOPIN, which is a drug marketed by Roche and is included in two NDAs. It is available from two suppliers. Additional details are available on the KLONOPIN profile page.

The generic ingredient in KLONOPIN is clonazepam. There are ten drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
Summary for 017533
Tradename:KLONOPIN
Applicant:Roche
Ingredient:clonazepam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017533
Ingredient-typeBenzodiazepines
Medical Subject Heading (MeSH) Categories for 017533
Suppliers and Packaging for NDA: 017533
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KLONOPIN clonazepam TABLET;ORAL 017533 NDA Genentech, Inc. 0004-0058 0004-0058-01 100 TABLET in 1 BOTTLE, PLASTIC (0004-0058-01)
KLONOPIN clonazepam TABLET;ORAL 017533 NDA Genentech, Inc. 0004-0068 0004-0068-01 100 TABLET in 1 BOTTLE, PLASTIC (0004-0068-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 017533

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN clonazepam TABLET;ORAL 017533-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Colorcon
Boehringer Ingelheim
Fish and Richardson
US Department of Justice
Federal Trade Commission
Harvard Business School
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.